IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q2 2021 Holdings

Filed 2021-08-11 | 7 holdings | $572.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$175.3K5,524,03130.6%
Pliant Therapeutics, Inc.(PLRX)COM729139105$170.0K5,839,16029.7%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$90.8K3,422,54915.9%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$62.5K5,962,20210.9%
Decibel Therapeutics, Inc.COM24343R106$27.0K3,139,6854.7%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$26.4K6,391,1764.6%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$20.7K3,048,7803.6%